|
New medicines recently added to the Pharmaceutical Benefits scheme (PBS) for preventing blood clots after hip or knee replacement surgery are reviewed in the latest edition of Medicine Update.
Medicine Update is an online publication produced by National Prescribing Service, designed to be used by consumers who are considering new medicines. It aims to highlight important information about how the medicine is used in therapy, how it compares with other therapies, provides any important safety information and explains the conditions of its listing on the PBS.
In the April issue, Medicine Update considers the benefits of dabigigatran (Praxada), and rivaroxaban (Xarelto), new oral anticoagulant medicines to prevent blood clots immediately after hip or knee replacement surgery.
For more information, see the full articles available at:
 www.nps.org.au
Patient Information
The Australian Rheumatology Association (ARA) and Arthritis Australia are pleased to provide the following co-badged medicine information, for your easy access click here
Updated 16 Aug 2010
|
Resize font:
